Ilsung Is Co., Ltd. (KRX:003120)

South Korea flag South Korea · Delayed Price · Currency is KRW
15,550
+50 (0.32%)
Feb 12, 2025, 9:00 AM KST
-34.39%
Market Cap 108.30B
Revenue (ttm) 74.17B
Net Income (ttm) -11.78B
Shares Out 6.97M
EPS (ttm) -1,735.65
PE Ratio n/a
Forward PE n/a
Dividend 1,500.00 (9.65%)
Ex-Dividend Date Dec 27, 2024
Volume 4,096
Average Volume 6,233
Open 15,500
Previous Close 15,500
Day's Range 15,460 - 15,580
52-Week Range 15,000 - 24,600
Beta -0.23
RSI 43.95
Earnings Date Feb 25, 2025

About Ilsung Is

Ilsung Is Co., Ltd. operates as a pharmaceutical company in South Korea. Its products include antibiotics, analgesics, muscle relaxants, antipyretic-analgesics, antihistamine, neuropsychiatric, neuromuscular blocker/ central muscle relaxants, anti-coagulants, probiotics, vaccine, medical equipment, circulatory system drugs, contrast agents, muscle relaxants, diabetes treatments, osteopathic, digestive system medicines, anti-virals, anti-emetics, respiratory treatments, adrenal cortical steroids, anesthetics, antipyretics, and cardiovascular sys... [Read more]

Sector Healthcare
Founded 1954
Country South Korea
Stock Exchange Korea Stock Exchange
Ticker Symbol 003120
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.